ICO — Iconovo AB Share News
0.000.00%
Last trade - 00:00- SEK104.83m
- SEK66.64m
- SEK1.10m
Brief: Iconovo Confirms Long-Term Targets For 2027
Brief: Iconovo Regains Global Rights To Sell, Distribute ICOcap® Inhalers
Brief: Iconovo Initiates Feasibility Study With Affilogic
Brief: Iconovo Initiates Collaboration With Small Danish Company
Brief: Iconovo Initiates Structured Process For Out-Licensing Of Icopre
Brief: Iconovo’S Partner Monash University Has Initiated A Phase I Clinical Trial On Inhaled Oxytocin In Icoone®
Brief: Iconovo Q1 Operating Loss Widens To SEK 12.9 Mln
Brief: Iconovo Receives New Patent In Japan For Inhaler Platform
Brief: Iconovo To Evaluate ICOone Nasal For Development Of Antiviral Nasal Inhalation Product
Brief: Iconovo Gets Wholesale License By Medical Products Agency
Brief: Iconovo Board Member, Major Shareholder Mats Johansson Acquires 75,000 Iconovo Shares
Brief: Iconovo Announces Positive Results From Project With Icoone Nasal
Brief: Iconovo Receives Approval Of New European Patent For Single-Use Inhaler
Brief: Iconovo Starts Talks On Potential Licensing Agreement For Its Icopre Inhaler
Brief: Iconovo Appoints Henrik Damkjær Simonsen As CFO
Brief: Iconovo's ICOone Receives New Us Patent Approval
Brief: Iconovo Appoints Peter Åkerlund As Interim CFO
Brief: Iconovo Q3 Operating Loss Widens To SEK 10.1 Million
Brief: Iconovo's CFO Leaves In Fourth Quarter Of 2022